Toremifene Citrate Tablets (Ovry®) – 60?mg
$1.00
Toremifene citrate (brand name Ovry®), manufactured by Jiangsu Ascend Pharmaceutical Co., Ltd., is a selective estrogen receptor modulator (SERM) approved in China (NMPA No.?H20243050, code?86901425001187). Each box contains 30 tablets (60?mg each) in 3 blister cards (barcode?6953272600284). Strictly for laboratory research purposes only.
描述
Toremifene Citrate Product Specifications
| Attribute | Details |
|---|---|
| Product Name | Toremifene Citrate Tablets (Ovry®) |
| Strength | 60?mg per tablet |
| Quantity | 10 tablets per blister × 3 blisters = 30 tablets per box |
| Dosage Form | Oral tablet |
| Approval No. | China NMPA?H20243050 |
| Product Code | 86901425001187 |
| Barcode | 6953272600284 |
| Manufacturer | Jiangsu Ascend Pharmaceutical Co., Ltd. |
| Intended Use | Laboratory research use only — Not for human use |
Mechanism of Action
Toremifene is a SERM that functions as an estrogen receptor antagonist in breast tissue, while having partial estrogenic effects in bones and lipid metabolism. It is widely used as a reference compound in estrogen-receptor assays and breast cancer model systems.
Research & Reference Data
-
Clinically approved for metastatic estrogen-receptor–positive breast cancer in post-menopausal women, at a dose of 60?mg once daily.
-
Pharmacokinetics: nearly 100% oral bioavailability, half-life of 3–7 days, high protein binding (~99.7%). en.wikipedia.org
-
Known to prolong QT interval; commonly used in studies evaluating cardiac safety and receptor interactions. pubchem.ncbi.nlm.nih.gov+9dailymed.nlm.nih.gov+9dailymed.nlm.nih.gov+9
Research Applications
-
ER+ breast cancer cell models
-
Receptor binding and signaling assays
-
SERM comparative pharmacology
-
QT prolongation modeling and toxicity screening
?? Disclaimer
This product is provided strictly for laboratory research and development use only.
其他信息
| 重量 | 1.1 公斤 |
|---|---|
| 尺寸 | 18 × 16 × 18 厘米 |
Toremifene Citrate Tablets (Ovry®) – 60?mg 有 1 个评价
相关产品
-
Palbociclib Capsules (Xipeilai) – 125?mg, 21 Capsules Price comparison
Palbociclib Capsules (Research Grade) in 125?mg strength, 21-count bottle. Supplied by Shanghai Chuannuo Pharmaceutical Co., Ltd. For investigational or research applications only—not for human consumption or therapeutic use.
$2.00 -
Lparomlimab & Tuvonralimab Injection (Qibeian) – 50?mg/2?mL Vial Price comparison
Lparomlimab & Tuvonralimab Injection Qibeian is a bi-functional monoclonal antibody combination (PD?1/CTLA?4) developed by Qilu Pharmaceutical (QL1706), supplied as 50?mg in 2?mL vials. Approved by China’s NMPA (conditional marketing authorization No. S20240044; drug code 86904021005238). Intended exclusively for lab and investigative research applications, not for clinical or human use. $1.00 -
Limertinib Tablets 80?mg ×?20 – by Osscon Pharma | Research Use Only (3rd?Gen EGFR?TKI)
Limertinib (OuyiXin®) is a third-generation EGFR tyrosine kinase inhibitor (EGFR?TKI) at 80?mg per tablet, 20 tablets per box, from Jiangsu Osscon Pharmaceutical. Approved by China’s NMPA under H20250004, it targets EGFR T790M?mutated non?small cell lung cancer, including patients with brain metastases.
?? For research use only – Not for human consumption or therapeutic use. $1.00 -
Pamidronate Disodium Injection 15?mg × 10 Vials Price comparison
High-purity Pamidronate Disodium 15?mg injectable solution, 10 vials per box. Manufactured by Chengdu Tiantai Shan Pharmaceutical Co., Ltd., it’s a nitrogen-containing bisphosphonate ideal for bone metabolism, osteoporosis, and oncology research.
?? For laboratory research purposes only – Not for human consumption or therapeutic use. $1.00
mood –
The package is damaged, you need to resend it to me, thank you